Top Suppliers:I want be here

872044-70-7

872044-70-7 structure
872044-70-7 structure
  • Name: AN0128
  • Chemical Name: 2-Pyridinecarboxylic acid, 3-hydroxy-, anhydride with B,B-bis(3-chloro-4-methylphenyl)borinic acid
  • CAS Number: 872044-70-7
  • Molecular Formula: C20H16BCl2NO3
  • Molecular Weight: 400.06300
  • Catalog: Signaling Pathways Anti-infection Bacterial
  • Create Date: 2017-06-09 12:06:05
  • Modify Date: 2025-08-25 11:49:30
  • AN0128 is a boron-containing antibacterial and anti-inflammatory agent. AN0128 against S. aureus, S. epidermidis, P. acnes, B. subtilis with minimum inhibitory concentration (MIC) values of 1, 0.5, 0.3, 1 μg/mL. AN0128 can be used for the research of periodontal disease and cutaneous diseases[1][2].

Name 2-Pyridinecarboxylic acid, 3-hydroxy-, anhydride with B,B-bis(3-chloro-4-methylphenyl)borinic acid
Synonyms 2-Pyridinecarboxylic acid, 3-hydroxy-, anhydride with bis(3-chloro-4-methylphenyl)borinic acid
Description AN0128 is a boron-containing antibacterial and anti-inflammatory agent. AN0128 against S. aureus, S. epidermidis, P. acnes, B. subtilis with minimum inhibitory concentration (MIC) values of 1, 0.5, 0.3, 1 μg/mL. AN0128 can be used for the research of periodontal disease and cutaneous diseases[1][2].
Related Catalog
In Vitro AN0128 (compound 2g; 10 μM; 24-48 hours) shows strong inhibition of the release of pro-inflammatory cytokines (TNF-α, IL-1β) but no inhibition of IFN-γ or IL-4 release in human peripheral blood mononuclear cells (PBMCs)[1].
In Vivo AN0128 (1%, 5%; daily topical daub for 7 days) significantly reduces the formation of an inflammatory infiltrate and reduces bone loss[2]. Animal Model: Experimental periodontitis in twelve-week-old male Sprague-Dawley rats (weighing from 275 to 300 g each)[2] Dosage: 1% AN0128 in 40% Transcutol P, 40% PBS, and 20% ethanol vehicle Administration: Daily topical daub for 7 days Result: Similar to Ketorolac, resulting 50% and 35% increase in bone area and bone volume respectively, and 38%, 42% decrease in bone loss and inflammation respectively. Animal Model: Experimental periodontitis in twelve-week-old male Sprague-Dawley rats (weighing from 275 to 300 g each)[2] Dosage: 5% with Total toothpaste Administration: Applied daily via a cotton-tip applicator. for 7 days Result: Had more effect than Total toothpaste, resulting in a 33% increase in bone volume, and a 47% decrease in bone loss.
References

[1]. Baker SJ, et al. Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseases. Bioorg Med Chem Lett. 2006 Dec 1;16(23):5963-7.

[2]. Luan Q, et al. Inhibition of experimental periodontitis by a topical boron-based antimicrobial. J Dent Res. 2008 Feb;87(2):148-52.

Molecular Formula C20H16BCl2NO3
Molecular Weight 400.06300
Exact Mass 399.06000
PSA 59.42000
LogP 3.67350
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.